Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer
- 24 June 2009
- journal article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 135 (12), 1783-1790
- https://doi.org/10.1007/s00432-009-0625-1
Abstract
The purpose of this retrospective study was to test whether the pretreatment hematologic profile can predict the prognosis of patients with head and neck cancer. Medical records from 278 patients with head and neck cancer were reviewed, and 270 cases were evaluable. Clinical data including age, gender, stage, pretreatment hematologic profile (including white blood cell, platelet, and differential counts, and hemoglobin level) were recorded. Statistical analyses were performed to determine the prognostic effect of these hematologic indicators, as well as clinical variables. The association between the hematologic indicators and clinical factors was also analyzed. Pretreatment monocytes >1,000 cells/μl (P = 0.028), hemoglobin 400 × 103 cells/μl (P = 0.017) were identified as independent prognostic factors in addition to the nodal status and metastasis. A significant correlation between T-stage/monocyte or platelet count and metastasis/platelet count were shown. Monocytosis, anemia, and thrombocytosis were demonstrated to have a cumulative effect on the prognosis of head and neck cancer patients (normal vs. abnormality in one lineage, P = 0.001; abnormality in one vs. more than one lineage, P = 0.005). A pretreatment hematologic profile can be considered as a useful prognostic marker in patients with head and neck cancer.Keywords
This publication has 40 references indexed in Scilit:
- VEGF concentration from plasma‐activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous modelJournal of Cellular and Molecular Medicine, 2009
- Pre-treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patientsClinical Otolaryngology, 2008
- The Staging of Cancer: A Retrospective and Prospective AppraisalCA: A Cancer Journal for Clinicians, 2008
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic CellsCancer Cell, 2008
- Preoperative thrombocytosis predicts poor survival in patients with glioblastomaNeuro-Oncology, 2007
- Monocyte/macrophage infiltration in tumors: modulators of angiogenesisJournal of Leukocyte Biology, 2006
- Hepatocellular carcinoma associated with acquired von Willebrand disease and extreme thrombocytosisAnnals of Oncology, 2005
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Prognostic significance of thrombocytosis in patients with primary lung cancerEuropean Respiratory Journal, 1996
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence DataBiometrics, 1973